T2 Biosystems, Inc. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 17 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-11-30: Reporting owner Gibbs Michael Terrence; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-11-30: Reporting owner McDonough John; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-11-30: Reporting owner Lowery Thomas J.; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-09-11: Reporting owner Barclay Alec; Form 4; Security Restricted Stock Unit; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-11-30 | Gibbs Michael Terrence Officer (General Counsel) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,500 0 owned after | $0.00 | 2019-02-05 | |
| 2018-11-30 | McDonough John Director, Officer (President & CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −47,422 0 owned after | $0.00 | 2019-02-05 | |
| 2018-11-30 | Lowery Thomas J. Officer (Chief Scientific Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 0 owned after | $0.00 | 2019-02-05 | |
| 2018-09-11 | Barclay Alec Officer (SVP, Operations) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 10,000 owned after | $0.00 | 2018-09-13 | |
| 2018-06-08 | Cima Michael J. Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $0.00 | 2018-06-12 | |
| 2018-06-08 | LIEBMAN SEYMOUR Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $0.00 | 2018-06-12 | |
| 2018-06-08 | Lapidus Stanley Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $0.00 | 2018-06-12 | |
| 2018-06-08 | Elsbree David B Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $0.00 | 2018-06-12 | |
| 2018-06-08 | CUMMING JOHN W Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $0.00 | 2018-06-12 | |
| 2018-03-15 | McDonough John Director, Officer (President & CEO) | 4 | Performance Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +434,783 434,783 owned after | $0.00 | 2018-03-19 | |
| 2018-03-15 | Lowery Thomas J. Officer (Chief Scientific Officer) | 4 | Performance Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +107,386 107,386 owned after | $0.00 | 2018-03-19 | |
| 2018-03-15 | Gibbs Michael Terrence Officer (General Counsel) | 4 | Performance Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +96,344 96,344 owned after | $0.00 | 2018-03-19 | |
| 2018-03-15 | Barclay Alec Officer (SVP, Operations) | 4 | Performance Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +96,344 96,344 owned after | $0.00 | 2018-03-19 | |
| 2018-03-15 | Sprague John M Officer (CFO) | 4 | Performance Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,170 69,170 owned after | $0.00 | 2018-03-19 | |
| 2018-03-14 holding as of filing | Barclay Alec Officer (SVP, Operations) | 3 | Restricted Stock Unit Derivative · Direct | Holding | no price filed | 2018-03-14 | ||
| 2018-01-01 | LIEBMAN SEYMOUR Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,708 9,708 owned after | $0.00 | 2018-01-03 | |
| 2018-01-01 | Elsbree David B Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,708 9,708 owned after | $0.00 | 2018-01-03 |